首页>
外国专利>
CONTROL OR ALLEVIATION OF SYMPTOM OR DISORDER CHARACTERIZED BY OR RELATED TO NEUROPEPTIDE Y
CONTROL OR ALLEVIATION OF SYMPTOM OR DISORDER CHARACTERIZED BY OR RELATED TO NEUROPEPTIDE Y
展开▼
机译:神经肽Y表征或相关的症状或病症的控制或缓解
展开▼
页面导航
摘要
著录项
相似文献
摘要
PROBLEM TO BE SOLVED: To obtain a medicine for suppressing or alleviating mammalian diseased symptoms or biological disorders characterized by neuropeptide (NPY) or related to NPY, by using a specific compound capable of controlling activity of the NPY by selectively bonding an NPY receptor. SOLUTION: An effective amount of a compound of the formula [R1 is methyl; R3 is phenyl; R2 is NH, (CH2 )3 COOH, piperidinyl or the like] or its salt is administered. A dose is preferably 0.1-15 mg/kg/day. A unit dosage form preferably contains 1-500 mg of the compound of the formula in general. In the case of orally or parenterally administering the compound to an animal, a dose is preferably 0.05-10 mg/kg/day. For example, obesity, hyperphagia, heart-related diseases such as cardiac failure, central nerve system-based diseases such as anxiety, schizophrenia, etc., may be cited as the diseased symptoms or biological disorders treatable by the compound of the formula.
展开▼
机译:解决的问题:通过使用能够选择性地结合NPY受体来控制NPY活性的特定化合物,获得用于抑制或减轻以神经肽(NPY)为特征或与NPY有关的哺乳动物疾病症状或生物学疾病的药物。溶液:有效量的式[R 1]化合物为甲基;其为甲基。 R 3为苯基; R 2为NH,(CH 2)3 COOH,哌啶基等]或其盐被给予。剂量优选为0.1-15mg / kg /天。一般而言,单位剂型优选包含1-500mg的式的化合物。在对动物口服或肠胃外施用化合物的情况下,剂量优选为0.05-10mg / kg /天。例如,肥胖,多食,与心脏有关的疾病如心力衰竭,基于中枢神经系统的疾病如焦虑症,精神分裂症等,可被引用为可通过该式的化合物治疗的疾病症状或生物学疾病。
展开▼